Fresenius Medical Care AG & Co KGaA (FMEG.DE)
15 Aug 2014
|Market Cap (Mil.):||€17,295.64|
|Shares Outstanding (Mil.):||310.70|
FRANKFURT, Oct 22 - Germany's Fresenius Medical Care (FMC) has agreed to buy National Cardiovascular Partners (NCP) to expand the range of services it offers linked to its core business of kidney dialysis.
Sept 16 - Fresenius Medical Care : * Says places equity-neutral convertible bonds * Says says placed equity-neutral convertible 1 bonds in an aggregate principal
FRANKFURT, Sept 16 - German kidney dialysis provider Fresenius Medical Care plans to issue 400 million euros ($518 million) in convertible bonds maturing in January 2020, it said on Tuesday.
Aug 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said on Friday it will remove an additional 25 products from its list of preferred drugs in 2015, including anemia drugs Epogen and Aranesp, sold by Amgen Inc.
- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc.
FRANKFURT, July 31 - German healthcare group Fresenius SE lifted its full-year sales outlook on Thursday to include acquisitions at its subsidiary Fresenius Medical Care.
(Adds Electrica, Allergan, Audika, Daimler and others; updates Fresenius Medical Care, Borussia Dortmund)
* FMC seeks to expand services linked to core dialysis ops
FRANKFURT, June 27 - Germany's Fresenius Medical Care (FMC) agreed to buy a majority stake in Sound Inpatient Physicians Inc for about $600 million, part of a drive to offer additional services linked to its core business of kidney dialysis.
SHANGHAI - China on Friday launched an anti-dumping investigation into makers of blood dialysis equipment in the European Union and Japan, including market leader Fresenius Medical Care (FMC) AG & Co KGaA, challenging the international firms who currently dominate the global and Chinese markets.
Earnings vs. Estimates
Analyst Research Reports
"The Economy Matters" Report for FMS: the economy's impact on FMS's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Fresenius Medical Care - Finlabo Research Equity Report: Fundamental and Technical Analysis and 6 months performance forecast
Provider: Finlabo SIM Spa
Provider: S&P Capital IQ – STARS Reports
Fresenius Medical Care AG & Co KGaA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.